<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39437850</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0631</ISSN><JournalIssue CitedMedium="Internet"><Volume>358</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Life sciences</Title><ISOAbbreviation>Life Sci</ISOAbbreviation></Journal><ArticleTitle>ACE and ACE2 activities and polymorphisms assessment: A populational study from Ipaussu (SP, Brazil) during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>123157</StartPage><MedlinePgn>123157</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2024.123157</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0024-3205(24)00747-1</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The angiotensin-converting enzyme 2 (ACE2) and its homolog, the angiotensin converting enzyme 1 (ACE), are involved in COVID-19 physiopathology. Alterations in the enzymatic structure, expression, and/or activity may influence the risk of infection and severity of disease. For this reason, we aimed to identify different allelic forms of ACE2 G8790A and ACE I/D polymorphisms in a Brazilian cohort and evaluate their impact on ACE and ACE2 activities and their association with COVID-19 susceptibility and severity.</AbstractText><AbstractText Label="MAIN METHODS" NlmCategory="METHODS">A total of 549 COVID-19-negative and 270 COVID-19-positive participants from Ipaussu, Sao Paulo, Brazil, were recruited. ACE2 and ACE activities were measured by fluorogenic assays using MCA-Ala-Pro-Lys(Dnp) as the substrate for ACE2 and Z-Phe-His-Leu-OH (Z-FHL) and Hippuryl-His-Leu-OH (h-HL) as substrates for ACE. Genomic DNA was extracted from EDTA-peripheral blood, and the regions of the genes containing ACE2 G8790A and ACE I/D polymorphisms were amplified by PCR-restriction fragment length polymorphism and real-time PCR, respectively.</AbstractText><AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">The G allele of ACE2 G8790A polymorphism and D allele of ACE I/D polymorphism are associated with increased ACE and ACE2 activities. ACE activity ratio (Z-FHL/h-HL), an inflammatory marker, is increased in women with GG genotype and COVID-19-positive diagnosis.</AbstractText><AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">For the first time, it was demonstrated that in females, the GG genotype is associated with increased ACE activity ratio (Z-FHL/h-HL) in the COVID-19-positive group. Elevated ACE activity ratio (Z-FHL/h-HL) is highly linked to inflammation and may justify the associations between the G genotype and COVID-19 severity of symptoms and outcomes.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favaroni Mendes Salgado Ribeiro</LastName><ForeName>Lys Angela</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Febba Gomes</LastName><ForeName>Andréia Cristina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azinheira Nobrega Cruz</LastName><ForeName>Nayara</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonçalves de Oliveira</LastName><ForeName>Lilian Caroline</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cenedeze</LastName><ForeName>Marcos Antonio</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedesco Silva Junior</LastName><ForeName>Hélio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina Pestana</LastName><ForeName>José Osmar</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casarini</LastName><ForeName>Dulce Elena</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Discipline of Nephrology, University Federal of Sao Paulo, Sao Paulo, Brazil. Electronic address: casarini.elena@unifesp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Life Sci</MedlineTA><NlmUniqueID>0375521</NlmUniqueID><ISSNLinking>0024-3205</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE insertion/deletion polymorphism</Keyword><Keyword MajorTopicYN="N">ACE2 G8790A polymorphism</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme 1</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme 2</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39437850</ArticleId><ArticleId IdType="doi">10.1016/j.lfs.2024.123157</ArticleId><ArticleId IdType="pii">S0024-3205(24)00747-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle>